BackAbsci Overview
Absci Corp

Absci Target Price

Analysts' average 12-month price target for Absci is $11.

Get informed when a big investor buys or sells

+ Follow

Share Price

$8.82

Average Target Price

$11.0224.9% upside

6 analysts in the last 4 months

High: $16 | Low: $4.1

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-06-25Morgan Stanley$1013.4% upsideOpen
2026-06-25H.C. Wainwright$1681.4% upsideOpen
2026-06-15Guggenheim$1570.1% upsideOpen
2026-06-04Leerink Partners$1236.1% upsideOpen
2026-05-28BTIG$92% upsideOpen
2026-05-14Morgan Stanley$4.153.5% downsideOpen
2026-01-08Morgan Stanley$4.3251% downsideOpen
2025-12-17H.C. Wainwright$89.3% downsideOpen
2024-03-21Stifel NicolausDaniel Arias$632% downsideOpen

Absci (ABSI) FAQ

Absci posts a target price of $11. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $11 for ABSI means covering analysts, on average, see the stock 24.9% upside of $8.82 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for ABSI's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Absci's other metric pages and overview cover the third.

Judging Absci against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $11 here, then scan peer and history charts to see if the gap is persistent.